When Patient Safety Becomes a Compliance Risk. What Chimamanda Adichie’s Story Means for Healthcare Governance in Nigeria

Chimamanda Adichie’s healthcare experience triggered debate, exposing deeper questions about patient safety, accountability, and compliance failures affecting Nigeria’s wider healthcare system. COMPLIANCE TODAY writes…

It often takes the voice of a public figure to expose problems that thousands experience in silence. When award winning author Chimamanda Ngozi Adichie recently shared her experience with Nigeria’s healthcare system, the story quickly transcended one patient’s account. It sparked a national conversation about medical negligence, patient safety, and accountability within healthcare institutions.

The public response was immediate. Media organisations amplified her concerns. Social media users recounted similar experiences. Medical professionals weighed in on standards of care, while regulators and healthcare stakeholders were drawn into a wider debate about patient rights and institutional responsibility.

Yet the attention surrounding the episode raises an uncomfortable question. If one of Africa’s most recognised writers needed her public profile to bring concerns about healthcare to the forefront, what happens to the millions of Nigerians whose experiences never receive national attention?

Every day, patients leave hospitals carrying unanswered questions after delayed diagnoses, communication failures, medication errors, surgical complications, or inadequate follow up care. Most of these stories never become newspaper headlines. They are quietly absorbed by families who often lack the financial resources, legal knowledge, or public influence to challenge the system. That reality is precisely why patient safety deserves to be viewed not simply as a clinical concern, but as a governance and compliance priority.

For healthcare leaders, the lesson extends far beyond any individual case. High profile incidents merely expose vulnerabilities that may already exist within institutional processes. The real compliance challenge is ensuring that patient safety does not depend on whether the person receiving treatment has public visibility or social influence.

Medical negligence occupies a unique place in healthcare regulation because it sits at the intersection of clinical judgement, professional ethics, legal accountability, and organisational governance. Not every adverse medical outcome amounts to negligence. Medicine is inherently uncertain, and complications can occur despite competent treatment. Nigerian law recognises this distinction by requiring claimants to establish that a healthcare provider owed a duty of care, breached that duty by failing to exercise reasonable professional skill, caused the injury complained of, and that measurable damage resulted.

While these legal principles appear straightforward, enforcing them is often far more complicated. Medical negligence litigation is technically demanding, expensive, and heavily dependent on expert testimony. Many patients struggle to obtain complete medical records or independent expert opinions. Court proceedings may take years, placing justice beyond the reach of many ordinary Nigerians. The gap between legal rights and practical enforcement underscores why effective compliance systems within healthcare institutions are so important. Preventing avoidable harm is invariably more effective than defending avoidable litigation.

Nigeria’s legal framework provides important protections for patients. The National Health Act establishes rights relating to informed consent, confidentiality, and access to emergency medical treatment. The Medical and Dental Practitioners Act regulates professional practice, while the Medical and Dental Council of Nigeria oversees licensing, ethics, and disciplinary proceedings. Together, these frameworks seek to ensure that healthcare professionals deliver services that meet acceptable standards of competence and integrity.

However, regulation alone cannot guarantee safer healthcare. Compliance begins inside healthcare institutions.

Too often, conversations about medical negligence focus exclusively on individual practitioners. In reality, many patients safety failures stem from systemic weaknesses rather than isolated mistakes. Inadequate staffing, outdated clinical protocols, poor communication between departments, weak supervision, equipment failures, and ineffective escalation procedures can all contribute to preventable harm. When these institutional shortcomings remain unaddressed, legal exposure extends beyond individual clinicians to the organisations responsible for maintaining safe systems of care.

This is where governance becomes central to patient safety.

Hospital boards and senior management increasingly have a responsibility to ensure that patient safety risks are identified, monitored, and mitigated through effective governance structures. Clinical governance should sit alongside financial governance, cyber resilience, and enterprise risk management as a strategic priority. Decisions concerning workforce planning, equipment procurement, infection prevention, digital record management, and quality assurance all have direct implications for patient outcomes and regulatory compliance.

Documentation represents one of the clearest examples of compliance in practice. Accurate medical records do far more than support continuity of care. They provide evidence that clinicians exercised appropriate professional judgement, obtained informed consent, communicated treatment options, and responded appropriately to changing clinical conditions. In negligence proceedings, courts frequently rely on medical records to determine whether reasonable standards of care were met. Poor documentation can significantly weaken a hospital’s legal position, even where treatment itself was clinically appropriate.

Informed consent presents another important compliance challenge. Patients have a legal right to understand proposed treatments, associated risks, available alternatives, and potential complications before consenting to medical intervention. Compliance requires more than obtaining a signature on a standard form. It demands meaningful communication that enables patients to make informed decisions about their healthcare. Institutions that reduce consent to an administrative exercise expose themselves to avoidable legal and reputational risk.

Equally important is how healthcare organisations respond when things go wrong. A mature compliance culture encourages early reporting of adverse events, transparent investigations, root cause analysis, and timely corrective action. Institutions that prioritise learning over blame are better positioned to reduce repeat incidents while strengthening public confidence. Conversely, cultures that discourage reporting or conceal errors often allow relatively minor failures to develop into major legal and reputational crises.

Complaint handling is another area where governance and patient safety intersect. Every complaint should be viewed as valuable risk intelligence rather than an inconvenience to be managed. Effective grievance mechanisms allow organisations to identify emerging patterns, address patient concerns promptly, and implement systemic improvements before problems escalate into litigation or regulatory scrutiny.

Technology is reshaping healthcare delivery, but it is also expanding compliance obligations. Electronic medical records, telemedicine platforms, artificial intelligence supported diagnostics, and digital health applications create opportunities to improve patient care while introducing new responsibilities relating to cybersecurity, data protection, and information governance. Healthcare organisations must ensure that technological innovation is accompanied by appropriate controls, staff training, and oversight.

The financial consequences of poor patient safety extend well beyond legal damages. Regulatory investigations, higher insurance costs, reputational harm, declining patient confidence, and increased operational scrutiny all carry significant commercial implications. In an increasingly competitive healthcare environment, institutional trust has become a strategic asset that requires continuous investment through effective governance and compliance.

For compliance professionals, the broader lesson from Chimamanda Adichie’s experience is not about celebrity. It is about consistency. Compliance frameworks should function with the same level of diligence regardless of whether the patient is a globally recognised author or an anonymous citizen seeking treatment at a local hospital. Accountability cannot depend on media attention. Governance systems should be designed to identify, investigate, and resolve patient safety concerns long before they become public controversies.

Ultimately, the debate sparked by Chimamanda’s story should encourage healthcare leaders to ask more difficult questions of their own institutions. Are patient safety risks actively monitored by the board? Do incident reporting systems encourage openness or silence? Are complaints analysed for systemic trends or treated as isolated events? Does compliance measure outcomes or merely verify procedures?

These questions will determine whether healthcare organisations are prepared for the future of regulation, where patient safety is increasingly viewed as a governance issue rather than solely a clinical responsibility.

The real significance of Chimamanda Adichie’s experience lies not in the prominence of the patient, but in what it revealed about the countless patients whose experiences never become national conversations. The law exists to protect them as well. Effective compliance ensures that hospitals do the same.